Literature DB >> 1905985

Adhesion characteristics of human interleukin 2-activated natural killer cells.

R J Melder1, E Walker, R B Herberman, T L Whiteside.   

Abstract

Culture of human monocyte-depleted peripheral blood mononuclear cells with recombinant IL2 (rIL2) induced adherence to plastic by 24 hr and subsequent proliferation in a subpopulation of lymphocytes with phenotypic and functional characteristics of activated natural killer (NK) cells. Purified human NK cells activated in the presence of IL2 for 24 hr upregulated the expression of the CD11c (p150.95) and CD11a antigen but not other cellular adhesion molecules (CAM). After further incubation with IL2, NK cells displayed upregulation of all of the antigens in the CD11/CD18 family of CAM. The process of adhesion was strictly dependent on culture in the presence of IL2, divalent cations, and active cellular metabolism. Adhesion also was dependent on expression of CAM on the cell surface, since monoclonal antibodies to CAM inhibited adhesion of activated NK cells to varying degrees (from 50 to 80%). An antibody (LeuM5) to the CD11c antigen (p150.95) gave the highest level of inhibition, and anti-CD11a (LFA-1) also was inhibitory, while anti-CD56 (NKH1) or anti-CD11b did not interfere with adhesion to plastic. Anti-CD11c was also the most effective in initiating the detachment of adherent-phase NK cells. Antibodies to CD18 or CD2 antigen also inhibited binding of NK cells to plastic. The blocking effects of anti-CD2 and anti-CD11a were additive in this system. On the surface of plastic-adherent and motile NK cells, all CAM except the CD56 antigen had a polar or bipolar distribution, as determined by staining with anti-CAM antibodies. Surface antigens CD11b, CD11c, CD2, and CD18 on nonadherent NK cells were clustered at the cellular poles by both immunofluorescence and immunogold electron microscopy, whereas CD11a (LFA-1) and CD56 antigens were distributed diffusely. CAM, especially CD11c, were also detected in cytoplasmic granules by immunostaining in IL2-activated NK cells. Thus, CAM may be stored in granules, allowing for their rapid transfer to the cell membrane in response to activation. Our results indicate that CAM are upregulated in IL2-activated NK cells and that some of these molecules (e.g., CD11c) play an important role in the development of plastic adherence by a subpopulation of these cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905985     DOI: 10.1016/0008-8749(91)90017-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation.

Authors:  L L Munn; R J Melder; R K Jain
Journal:  Biophys J       Date:  1996-07       Impact factor: 4.033

2.  Expression and functional activity of the very late activation antigen-4 molecule on human natural killer cells in different states of activation.

Authors:  C Macías; J M Ballester; P Hernández
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

3.  Mycoplasma arthritidis mitogen up-regulates human NK cell activity.

Authors:  J A D'Orazio; B C Cole; J Stein-Streilein
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

4.  Detection of cell-adhesion molecules on human liver-associated lymphocytes.

Authors:  M Garcìa-Barcina; M Winnock; I Bidaurrazaga; S Huet; P Bioulac-Sage; C Balabaud
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

5.  Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity.

Authors:  D Raspadori; F Lauria; M A Ventura; D Rondelli; S Tura
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

6.  Kinetics of interleukin-2 induced changes in rigidity of human natural killer cells.

Authors:  R J Melder; R K Jain
Journal:  Cell Biophys       Date:  1992 Apr-Jun

7.  Expression of cell adhesion molecules on liver-associated lymphocytes and their ligands on sinusoidal lining cells in patients with benign or malignant liver disease.

Authors:  M García-Barcina; B Lukomska; W Gawron; M Winnock; F Vidal-Vanaclocha; P Bioulac-Sage; C Balabaud; W Olszewski
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

Review 8.  Role of human natural killer cells in health and disease.

Authors:  T L Whiteside; R B Herberman
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

Review 9.  "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy.

Authors:  Senthamil R Selvan; John P Dowling
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

10.  Cancer immunotherapy with interleukin-2-activated natural killer cells.

Authors:  Per H Basse; Theresa L Whiteside; Ronald B Herberman
Journal:  Mol Biotechnol       Date:  2002-06       Impact factor: 2.860

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.